Comparison of Intraurethral lidocaine gel with and without nitrous oxide and oxygen mixture inhalation on rigid cystoscopy for pain management

Phase 3

• Conditions: Inclusion Criteria1.Patient who was performed by use rigid cystoscopy size 22 Fr2.Patient who was performed by use rigid cystoscopy size 22 Fr with tissue biopsy at bladder mucosa3.Patient who was performed by use rigid cystoscopy size 22 Fr with ureteral insertion size 6 Fr4.Femal and male patients age above 18 Yrs old; Pain; Cystoscopy; Entonox

• Registration Number: TCTR20211106001
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-11-06
• Study Completion: 2022-04-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

1.Patient who was performed with Rigid Cystoscopy for diagnosis (22 Fr Size)
2.Patient who was performed with Rigid Cystoscopy and bladder biopsy for diagnosis (22 Fr Size)
3.Patient who was performed with Rigid Cystoscopy and ureteral stent insertion (22 Fr for Rigid Cystoscopy and 6 Fr for ureteral stent)

Exclusion Criteria

1.patient who refuse this project
2.History of lidocaine or nitrous mixture halation allergy
3.patient with impairing pain perception
4.patient with maxillofacial injury
5.patient with pneumothorax

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain Control every 15 minutes during cystoscopy and after immediate cystoscopy and 15 minutes after that Numeric rating Scale

Secondary Outcome Measures

Name	Time	Method
Side Effect of Enotonox 1 Year Questionnaire interview